Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vanda Pharmaceuticals Inc. - Common Stock
(NQ:
VNDA
)
5.580
+0.380 (+7.31%)
Streaming Delayed Price
Updated: 11:27 AM EST, Dec 5, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vanda Pharmaceuticals Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Stocks That Hit 52-Week Lows On Friday
↗
February 24, 2023
On Friday, 135 companies reached new 52-week lows.
Via
Benzinga
Why Vanda Pharmaceuticals Stock Crawled Higher Today
↗
February 09, 2023
A solid earnings beat drove the company's share price upward.
Via
The Motley Fool
Earnings Preview: Vanda Pharmaceuticals
↗
February 07, 2023
Via
Benzinga
Vanda Pharma's Antipsychotic Shows Improved Severity In Bipolar Disorder
↗
December 19, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
December 16, 2022
During Friday's trading, 293 companies set new 52-week lows.
Via
Benzinga
Looking Into Vanda Pharmaceuticals's Return On Capital Employed
↗
August 10, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
December 14, 2022
On Wednesday, 115 stocks hit new 52-week lows.
Via
Benzinga
Recap: Vanda Pharma Q2 Earnings
↗
August 03, 2022
Vanda Pharma (NASDAQ:VNDA) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
February 04, 2022
On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap...
Via
Benzinga
JetBlue Airways, Pacira BioSciences And Some Other Big Stocks Moving Lower On Tuesday
↗
December 13, 2022
U.S. stocks traded slightly higher, with the Nasdaq Composite gaining around 70 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
December 13, 2022
Via
Benzinga
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
↗
August 03, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
↗
December 13, 2022
Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
May 06, 2022
Via
Benzinga
Earnings Scheduled For November 2, 2022
↗
November 02, 2022
Companies Reporting Before The Bell • Nomura Holdings (NYSE:NMR) is likely to report earnings for its second quarter.
Via
Benzinga
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
↗
May 05, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Earnings Scheduled For May 5, 2022
↗
May 05, 2022
Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
Via
Benzinga
Earnings Outlook For Vanda Pharmaceuticals
↗
May 04, 2022
Vanda Pharmaceuticals (NASDAQ:VNDA) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Vanda...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 25, 2022
↗
February 25, 2022
Upgrades According to 86 Research, the prior rating for NetEase Inc (NASDAQ:NTES) was changed from Hold to Buy. For the fourth quarter, NetEase had an EPS of $1.56,...
Via
Benzinga
10 Biggest Price Target Changes For Friday
↗
February 25, 2022
Daiwa Capital cut the price target on Tesla, Inc. (NASDAQ: TSLA) from $980 to $900. Tesla shares rose 1.3% to $811.13 in pre-market trading.
Via
Benzinga
93 Biggest Movers From Friday
↗
February 28, 2022
Gainers Inspirato Incorporated (NASDAQ: ISPO) shares surged 50.5% to close at $54.90. Guardforce AI Co., Limited (NASDAQ: GFAI) jumped 45.4% to settle at $0.5979 on Friday. EF...
Via
Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
↗
February 24, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (...
Via
Benzinga
Vanda Pharmaceuticals: Q4 Earnings Insights
↗
February 23, 2022
Vanda Pharmaceuticals (NASDAQ:VNDA) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM. Here's what investors need to know about the announcement....
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
February 23, 2022
Gainers SCYNEXIS (NASDAQ:SCYX) shares inc...
Via
Benzinga
Earnings Scheduled For February 23, 2022
↗
February 23, 2022
Companies Reporting Before The Bell • Sapiens Intl Corp (NASDAQ:SPNS) is likely to report earnings for its fourth quarter. • Plymouth Industrial REIT (NYSE:PLYM)...
Via
Benzinga
50 Biggest Movers From Friday
↗
February 07, 2022
Also check out this: Executives Sell Over $45M Of 5 Stocks Losers Ra Medical Systems, Inc. (NYSE: RMED) shares dipped 48.8% to close at $0.3599 on Friday after the...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
February 04, 2022
Gainers Quidel (NASDAQ:QDEL) shares incre...
Via
Benzinga
Mid-Afternoon Market Update: Dow Turns Positive; Snap Shares Climb Following Upbeat Results
↗
February 04, 2022
The Dow Jones turned higher later in the session on Friday following upbeat earnings from Amazon.com, Inc. (NASDAQ: AMZN) and strong payrolls report for January.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
February 04, 2022
Gainers iRadimed (NASDAQ:IRMD) stock rose 15.0% to $45.19 during Friday's regular session. Trading volume for iRadimed's stock is 94.1K as of 12:30 EST. This is...
Via
Benzinga
Tech Earnings Prop Up Nasdaq as Bond Yields Rise
↗
February 04, 2022
The Dow Jones Industrial Average is down 260 points midday, as a spike in the 10-year Treasury yield puts pressure on the market.
Via
Talk Markets
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today